HDAC inhibitors and their role in treating anaplastic thyroid carcinoma - Mayo Clinic

Pomalidomide and HDAC Inhibitors in Multiple Myeloma | OncLive

Vividion & Bayer's WRN Inhibitor: Cancer Drug Development – Archyde

Researchers decode molecular action of combination therapy for a deadly thyroid cancer - Mayo Clinic News Network

Did you know about Hepatic Artery Infusion (HAI)? 🤔 This innovative cancer treatment delivers chemotherapy directly to liver tumors, offering a powerful and targeted approach for patients with metastatic colorectal cancer (cancer that has spread from the colon or rectum to the liver) and intrahepatic cholangiocarcinoma (cancer that develops in the cells within the bile ducts both inside and outside the liver). By focusing the treatment where it's needed most, HAI can reduce side effects and imp